Literature DB >> 26628567

Establishing a Fecal Microbiota Transplant Service for the Treatment of Clostridium difficile Infection.

Samuel P Costello1, Emily C Tucker2, Justin La Brooy3, Mark N Schoeman4, Jane M Andrews4.   

Abstract

Recurrent or refractory Clostridium difficile infection (CDI) has become an increasing problem in the past decade. Fecal microbiota transplant (FMT) is a highly efficacious treatment for recurrent CDI; however, a number of technical, logistical, and regulatory issues have hampered the development of an FMT capability at many hospitals. The development of a frozen stool bank of screened donor stool is an important step in the standardization of the procedure. This gives clinicians rapid access to thoroughly screened donor stool when needed, without the ethical and logistical problems associated with patient-selected donors. We describe the practicalities of establishing such a service using a stool bank of prescreened donor stool including detail regarding donor recruitment and screening, stool preparation, and delivery of the FMT.
© The Author 2015. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  Clostridium difficile; donor; fecal microbiota transplant; screening; stool bank

Mesh:

Year:  2015        PMID: 26628567     DOI: 10.1093/cid/civ994

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  35 in total

Review 1.  Technical Aspects of Fecal Microbial Transplantation (FMT).

Authors:  N Bhutiani; J E Schucht; K R Miller; Stephen A McClave
Journal:  Curr Gastroenterol Rep       Date:  2018-06-09

2.  Establishing a donor stool bank for faecal microbiota transplantation: methods and feasibility.

Authors:  Anne A Rode; Peter Bytzer; Ole Birger Pedersen; Jørgen Engberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-07-04       Impact factor: 3.267

Review 3.  THE POWER OF POOP: FECAL MICROBIOTA TRANSPLANTATION FOR CLOSTRIDIUM DIFFICILE INFECTION.

Authors:  Michael B Edmond
Journal:  Trans Am Clin Climatol Assoc       Date:  2016

4.  Transfer of altered behaviour and irritable bowel syndrome with diarrhea (IBS-D) through fecal microbiota transplant in mouse model indicates need for stricter donor screening criteria.

Authors:  Laura J Craven; Michael Silverman; Jeremy P Burton
Journal:  Ann Transl Med       Date:  2017-12

5.  Is it reasonable to perform Fecal Microbiota Transplantation for recurrent Clostridium difficile Infection in patients with liver cirrhosis?

Authors:  M Olmedo; E Reigadas; M Valerio; S Vázquez-Cuesta; J A Pajares; A Matilla; P Muñoz; E Bouza
Journal:  Rev Esp Quimioter       Date:  2019-03-08       Impact factor: 1.553

Review 6.  Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection.

Authors:  Brendan J Kelly; Pablo Tebas
Journal:  Chest       Date:  2017-09-18       Impact factor: 9.410

7.  Regional variability in fecal microbiota transplantation practices: a survey of the Southern Ontario Fecal Microbiota Transplantation Movement.

Authors:  Susy S Hota; Salman Surangiwala; Aimee S Paterson; Bryan Coburn; Susan M Poutanen
Journal:  CMAJ Open       Date:  2018-04-18

8.  Challenges and costs of donor screening for fecal microbiota transplantations.

Authors:  Mèlanie V Bénard; Clara M A de Bruijn; Aline C Fenneman; Koen Wortelboer; Judith Zeevenhoven; Bente Rethans; Hilde J Herrema; Tom van Gool; Max Nieuwdorp; Marc A Benninga; Cyriel Y Ponsioen
Journal:  PLoS One       Date:  2022-10-20       Impact factor: 3.752

Review 9.  Therapeutic manipulation of the microbiota: past, present, and considerations for the future.

Authors:  V B Young
Journal:  Clin Microbiol Infect       Date:  2016-09-10       Impact factor: 8.067

Review 10.  A Comparison of Current Guidelines of Five International Societies on Clostridium difficile Infection Management.

Authors:  Csaba Fehér; Josep Mensa
Journal:  Infect Dis Ther       Date:  2016-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.